nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—Cytochrome P450 3A4 Inhibitors—Pazopanib—kidney cancer	0.297	0.5	CiPCiCtD
Aprepitant—Cytochrome P450 3A4 Inhibitors—Everolimus—kidney cancer	0.297	0.5	CiPCiCtD
Aprepitant—TACR3—iris—kidney cancer	0.0338	0.809	CbGeAlD
Aprepitant—CYP3A7—Temsirolimus—kidney cancer	0.0263	0.108	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0263	0.108	CbGbCtD
Aprepitant—CYP3A5—Temsirolimus—kidney cancer	0.0198	0.0811	CbGbCtD
Aprepitant—CYP3A4—Everolimus—kidney cancer	0.0114	0.0468	CbGbCtD
Aprepitant—CYP3A7—Paclitaxel—kidney cancer	0.00904	0.0371	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.00904	0.0371	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.00803	0.033	CbGbCtD
Aprepitant—CYP3A7—Sorafenib—kidney cancer	0.00803	0.033	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.00779	0.032	CbGbCtD
Aprepitant—CYP3A7—Vincristine—kidney cancer	0.00779	0.032	CbGbCtD
Aprepitant—CYP1A2—Pazopanib—kidney cancer	0.00773	0.0317	CbGbCtD
Aprepitant—CYP3A4—Temsirolimus—kidney cancer	0.00771	0.0316	CbGbCtD
Aprepitant—CYP3A5—Erlotinib—kidney cancer	0.00741	0.0304	CbGbCtD
Aprepitant—CYP2C9—Capecitabine—kidney cancer	0.00726	0.0298	CbGbCtD
Aprepitant—CYP3A5—Paclitaxel—kidney cancer	0.00678	0.0278	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00651	0.0267	CbGbCtD
Aprepitant—CYP3A7—Sunitinib—kidney cancer	0.00651	0.0267	CbGbCtD
Aprepitant—CYP3A5—Sorafenib—kidney cancer	0.00602	0.0247	CbGbCtD
Aprepitant—CYP3A5—Vincristine—kidney cancer	0.00585	0.024	CbGbCtD
Aprepitant—CYP1A2—Erlotinib—kidney cancer	0.00551	0.0226	CbGbCtD
Aprepitant—CYP3A5—Sunitinib—kidney cancer	0.00488	0.02	CbGbCtD
Aprepitant—CYP2C19—Sorafenib—kidney cancer	0.00486	0.0199	CbGbCtD
Aprepitant—CYP2C9—Paclitaxel—kidney cancer	0.00455	0.0187	CbGbCtD
Aprepitant—CYP1A2—Sorafenib—kidney cancer	0.00448	0.0184	CbGbCtD
Aprepitant—CYP3A4—Pazopanib—kidney cancer	0.00405	0.0166	CbGbCtD
Aprepitant—CYP2C9—Sorafenib—kidney cancer	0.00404	0.0166	CbGbCtD
Aprepitant—CYP3A4—Erlotinib—kidney cancer	0.00289	0.0119	CbGbCtD
Aprepitant—CYP3A4—Paclitaxel—kidney cancer	0.00264	0.0109	CbGbCtD
Aprepitant—CYP3A4—Sorafenib—kidney cancer	0.00235	0.00964	CbGbCtD
Aprepitant—CYP3A4—Vinblastine—kidney cancer	0.00232	0.00952	CbGbCtD
Aprepitant—CYP3A4—Vincristine—kidney cancer	0.00228	0.00936	CbGbCtD
Aprepitant—CYP3A4—Sunitinib—kidney cancer	0.0019	0.00781	CbGbCtD
Aprepitant—CYP3A4—Doxorubicin—kidney cancer	0.00142	0.00585	CbGbCtD
Aprepitant—CYP2C19—urine—kidney cancer	0.00132	0.0317	CbGeAlD
Aprepitant—CYP1A2—urine—kidney cancer	0.00108	0.0259	CbGeAlD
Aprepitant—CYP2C9—urine—kidney cancer	0.00103	0.0246	CbGeAlD
Aprepitant—TACR1—renal system—kidney cancer	0.000848	0.0203	CbGeAlD
Aprepitant—CYP3A4—urine—kidney cancer	0.000783	0.0187	CbGeAlD
Aprepitant—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000678	0.0162	CbGeAlD
Aprepitant—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.00058	0.0139	CbGeAlD
Aprepitant—CYP3A5—nephron tubule—kidney cancer	0.000281	0.00672	CbGeAlD
Aprepitant—CYP1A2—renal system—kidney cancer	0.000265	0.00633	CbGeAlD
Aprepitant—CYP3A5—renal system—kidney cancer	0.000255	0.0061	CbGeAlD
Aprepitant—CYP3A5—kidney—kidney cancer	0.000247	0.0059	CbGeAlD
Aprepitant—CYP3A5—cortex of kidney—kidney cancer	0.00024	0.00575	CbGeAlD
Aprepitant—CYP3A4—renal system—kidney cancer	0.000191	0.00458	CbGeAlD
Aprepitant—CYP3A4—kidney—kidney cancer	0.000185	0.00443	CbGeAlD
Aprepitant—Fatigue—Gemcitabine—kidney cancer	3.07e-05	0.000296	CcSEcCtD
Aprepitant—Gastrointestinal pain—Vincristine—kidney cancer	3.06e-05	0.000296	CcSEcCtD
Aprepitant—Dizziness—Sorafenib—kidney cancer	3.05e-05	0.000294	CcSEcCtD
Aprepitant—Pain—Gemcitabine—kidney cancer	3.04e-05	0.000294	CcSEcCtD
Aprepitant—Constipation—Gemcitabine—kidney cancer	3.04e-05	0.000294	CcSEcCtD
Aprepitant—Nausea—Erlotinib—kidney cancer	3.04e-05	0.000294	CcSEcCtD
Aprepitant—Alopecia—Capecitabine—kidney cancer	3.04e-05	0.000293	CcSEcCtD
Aprepitant—Dry mouth—Paclitaxel—kidney cancer	3.04e-05	0.000293	CcSEcCtD
Aprepitant—Diarrhoea—Sunitinib—kidney cancer	3.03e-05	0.000293	CcSEcCtD
Aprepitant—Mental disorder—Capecitabine—kidney cancer	3.01e-05	0.000291	CcSEcCtD
Aprepitant—Asthenia—Dactinomycin—kidney cancer	3.01e-05	0.000291	CcSEcCtD
Aprepitant—Confusional state—Paclitaxel—kidney cancer	3e-05	0.00029	CcSEcCtD
Aprepitant—Blood creatinine increased—Doxorubicin—kidney cancer	3e-05	0.00029	CcSEcCtD
Aprepitant—Malnutrition—Capecitabine—kidney cancer	2.99e-05	0.000289	CcSEcCtD
Aprepitant—Erythema—Capecitabine—kidney cancer	2.99e-05	0.000289	CcSEcCtD
Aprepitant—Dehydration—Doxorubicin—kidney cancer	2.98e-05	0.000288	CcSEcCtD
Aprepitant—Anaphylactic shock—Paclitaxel—kidney cancer	2.98e-05	0.000288	CcSEcCtD
Aprepitant—Oedema—Paclitaxel—kidney cancer	2.98e-05	0.000288	CcSEcCtD
Aprepitant—Abdominal pain—Vincristine—kidney cancer	2.96e-05	0.000286	CcSEcCtD
Aprepitant—Body temperature increased—Vincristine—kidney cancer	2.96e-05	0.000286	CcSEcCtD
Aprepitant—Infection—Paclitaxel—kidney cancer	2.96e-05	0.000286	CcSEcCtD
Aprepitant—Flatulence—Capecitabine—kidney cancer	2.95e-05	0.000285	CcSEcCtD
Aprepitant—Dysgeusia—Capecitabine—kidney cancer	2.93e-05	0.000283	CcSEcCtD
Aprepitant—Dizziness—Sunitinib—kidney cancer	2.93e-05	0.000283	CcSEcCtD
Aprepitant—Feeling abnormal—Gemcitabine—kidney cancer	2.93e-05	0.000283	CcSEcCtD
Aprepitant—Shock—Paclitaxel—kidney cancer	2.93e-05	0.000283	CcSEcCtD
Aprepitant—Vomiting—Sorafenib—kidney cancer	2.93e-05	0.000283	CcSEcCtD
Aprepitant—Abdominal pain upper—Doxorubicin—kidney cancer	2.93e-05	0.000283	CcSEcCtD
Aprepitant—Nervous system disorder—Paclitaxel—kidney cancer	2.92e-05	0.000282	CcSEcCtD
Aprepitant—Hypokalaemia—Doxorubicin—kidney cancer	2.92e-05	0.000282	CcSEcCtD
Aprepitant—Thrombocytopenia—Paclitaxel—kidney cancer	2.91e-05	0.000281	CcSEcCtD
Aprepitant—Tachycardia—Paclitaxel—kidney cancer	2.91e-05	0.000281	CcSEcCtD
Aprepitant—Rash—Sorafenib—kidney cancer	2.9e-05	0.00028	CcSEcCtD
Aprepitant—Dermatitis—Sorafenib—kidney cancer	2.9e-05	0.00028	CcSEcCtD
Aprepitant—Back pain—Capecitabine—kidney cancer	2.9e-05	0.00028	CcSEcCtD
Aprepitant—Breast disorder—Doxorubicin—kidney cancer	2.9e-05	0.00028	CcSEcCtD
Aprepitant—Skin disorder—Paclitaxel—kidney cancer	2.89e-05	0.000279	CcSEcCtD
Aprepitant—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	2.89e-05	0.000279	CcSEcCtD
Aprepitant—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	2.89e-05	0.000279	CcSEcCtD
Aprepitant—Headache—Sorafenib—kidney cancer	2.88e-05	0.000279	CcSEcCtD
Aprepitant—Muscle spasms—Capecitabine—kidney cancer	2.88e-05	0.000278	CcSEcCtD
Aprepitant—Hyperhidrosis—Paclitaxel—kidney cancer	2.88e-05	0.000278	CcSEcCtD
Aprepitant—Diarrhoea—Dactinomycin—kidney cancer	2.87e-05	0.000277	CcSEcCtD
Aprepitant—Anorexia—Paclitaxel—kidney cancer	2.84e-05	0.000274	CcSEcCtD
Aprepitant—Gastritis—Doxorubicin—kidney cancer	2.84e-05	0.000274	CcSEcCtD
Aprepitant—Muscular weakness—Doxorubicin—kidney cancer	2.83e-05	0.000273	CcSEcCtD
Aprepitant—Alanine aminotransferase increased—Doxorubicin—kidney cancer	2.83e-05	0.000273	CcSEcCtD
Aprepitant—Vomiting—Sunitinib—kidney cancer	2.82e-05	0.000272	CcSEcCtD
Aprepitant—Body temperature increased—Gemcitabine—kidney cancer	2.81e-05	0.000271	CcSEcCtD
Aprepitant—Tremor—Capecitabine—kidney cancer	2.8e-05	0.000271	CcSEcCtD
Aprepitant—Rash—Sunitinib—kidney cancer	2.79e-05	0.00027	CcSEcCtD
Aprepitant—Dermatitis—Sunitinib—kidney cancer	2.79e-05	0.00027	CcSEcCtD
Aprepitant—Abdominal distension—Doxorubicin—kidney cancer	2.79e-05	0.000269	CcSEcCtD
Aprepitant—Hypotension—Paclitaxel—kidney cancer	2.78e-05	0.000269	CcSEcCtD
Aprepitant—Ill-defined disorder—Capecitabine—kidney cancer	2.78e-05	0.000268	CcSEcCtD
Aprepitant—Headache—Sunitinib—kidney cancer	2.78e-05	0.000268	CcSEcCtD
Aprepitant—Dysphagia—Doxorubicin—kidney cancer	2.77e-05	0.000267	CcSEcCtD
Aprepitant—Anaemia—Capecitabine—kidney cancer	2.77e-05	0.000267	CcSEcCtD
Aprepitant—Hypersensitivity—Vincristine—kidney cancer	2.76e-05	0.000267	CcSEcCtD
Aprepitant—Nausea—Sorafenib—kidney cancer	2.74e-05	0.000264	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Paclitaxel—kidney cancer	2.71e-05	0.000262	CcSEcCtD
Aprepitant—Malaise—Capecitabine—kidney cancer	2.7e-05	0.000261	CcSEcCtD
Aprepitant—Insomnia—Paclitaxel—kidney cancer	2.69e-05	0.00026	CcSEcCtD
Aprepitant—Asthenia—Vincristine—kidney cancer	2.69e-05	0.00026	CcSEcCtD
Aprepitant—Syncope—Capecitabine—kidney cancer	2.68e-05	0.000259	CcSEcCtD
Aprepitant—Paraesthesia—Paclitaxel—kidney cancer	2.67e-05	0.000258	CcSEcCtD
Aprepitant—Vomiting—Dactinomycin—kidney cancer	2.67e-05	0.000258	CcSEcCtD
Aprepitant—Dyspnoea—Paclitaxel—kidney cancer	2.65e-05	0.000256	CcSEcCtD
Aprepitant—Somnolence—Paclitaxel—kidney cancer	2.65e-05	0.000256	CcSEcCtD
Aprepitant—Palpitations—Capecitabine—kidney cancer	2.65e-05	0.000255	CcSEcCtD
Aprepitant—Rash—Dactinomycin—kidney cancer	2.65e-05	0.000255	CcSEcCtD
Aprepitant—Nausea—Sunitinib—kidney cancer	2.63e-05	0.000254	CcSEcCtD
Aprepitant—Loss of consciousness—Capecitabine—kidney cancer	2.63e-05	0.000254	CcSEcCtD
Aprepitant—Dyspepsia—Paclitaxel—kidney cancer	2.62e-05	0.000253	CcSEcCtD
Aprepitant—Cough—Capecitabine—kidney cancer	2.61e-05	0.000252	CcSEcCtD
Aprepitant—Dysuria—Doxorubicin—kidney cancer	2.59e-05	0.00025	CcSEcCtD
Aprepitant—Neutropenia—Doxorubicin—kidney cancer	2.59e-05	0.00025	CcSEcCtD
Aprepitant—Decreased appetite—Paclitaxel—kidney cancer	2.59e-05	0.00025	CcSEcCtD
Aprepitant—Hypertension—Capecitabine—kidney cancer	2.58e-05	0.00025	CcSEcCtD
Aprepitant—Upper respiratory tract infection—Doxorubicin—kidney cancer	2.57e-05	0.000249	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Paclitaxel—kidney cancer	2.57e-05	0.000248	CcSEcCtD
Aprepitant—Fatigue—Paclitaxel—kidney cancer	2.57e-05	0.000248	CcSEcCtD
Aprepitant—Diarrhoea—Vincristine—kidney cancer	2.56e-05	0.000248	CcSEcCtD
Aprepitant—Pollakiuria—Doxorubicin—kidney cancer	2.56e-05	0.000247	CcSEcCtD
Aprepitant—Asthenia—Gemcitabine—kidney cancer	2.55e-05	0.000246	CcSEcCtD
Aprepitant—Myalgia—Capecitabine—kidney cancer	2.55e-05	0.000246	CcSEcCtD
Aprepitant—Chest pain—Capecitabine—kidney cancer	2.55e-05	0.000246	CcSEcCtD
Aprepitant—Arthralgia—Capecitabine—kidney cancer	2.55e-05	0.000246	CcSEcCtD
Aprepitant—Pain—Paclitaxel—kidney cancer	2.55e-05	0.000246	CcSEcCtD
Aprepitant—Constipation—Paclitaxel—kidney cancer	2.55e-05	0.000246	CcSEcCtD
Aprepitant—Anxiety—Capecitabine—kidney cancer	2.54e-05	0.000245	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	2.53e-05	0.000244	CcSEcCtD
Aprepitant—Photosensitivity reaction—Doxorubicin—kidney cancer	2.53e-05	0.000244	CcSEcCtD
Aprepitant—Weight increased—Doxorubicin—kidney cancer	2.52e-05	0.000243	CcSEcCtD
Aprepitant—Discomfort—Capecitabine—kidney cancer	2.52e-05	0.000243	CcSEcCtD
Aprepitant—Pruritus—Gemcitabine—kidney cancer	2.52e-05	0.000243	CcSEcCtD
Aprepitant—Weight decreased—Doxorubicin—kidney cancer	2.51e-05	0.000242	CcSEcCtD
Aprepitant—Hyperglycaemia—Doxorubicin—kidney cancer	2.5e-05	0.000241	CcSEcCtD
Aprepitant—Dry mouth—Capecitabine—kidney cancer	2.49e-05	0.000241	CcSEcCtD
Aprepitant—Nausea—Dactinomycin—kidney cancer	2.49e-05	0.000241	CcSEcCtD
Aprepitant—Pneumonia—Doxorubicin—kidney cancer	2.48e-05	0.00024	CcSEcCtD
Aprepitant—Dizziness—Vincristine—kidney cancer	2.48e-05	0.000239	CcSEcCtD
Aprepitant—Infestation—Doxorubicin—kidney cancer	2.47e-05	0.000238	CcSEcCtD
Aprepitant—Infestation NOS—Doxorubicin—kidney cancer	2.47e-05	0.000238	CcSEcCtD
Aprepitant—Confusional state—Capecitabine—kidney cancer	2.46e-05	0.000238	CcSEcCtD
Aprepitant—Feeling abnormal—Paclitaxel—kidney cancer	2.45e-05	0.000237	CcSEcCtD
Aprepitant—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	2.45e-05	0.000236	CcSEcCtD
Aprepitant—Oedema—Capecitabine—kidney cancer	2.44e-05	0.000236	CcSEcCtD
Aprepitant—Gastrointestinal pain—Paclitaxel—kidney cancer	2.43e-05	0.000235	CcSEcCtD
Aprepitant—Diarrhoea—Gemcitabine—kidney cancer	2.43e-05	0.000235	CcSEcCtD
Aprepitant—Renal failure—Doxorubicin—kidney cancer	2.43e-05	0.000234	CcSEcCtD
Aprepitant—Infection—Capecitabine—kidney cancer	2.43e-05	0.000234	CcSEcCtD
Aprepitant—Neuropathy peripheral—Doxorubicin—kidney cancer	2.42e-05	0.000234	CcSEcCtD
Aprepitant—Stomatitis—Doxorubicin—kidney cancer	2.41e-05	0.000232	CcSEcCtD
Aprepitant—Shock—Capecitabine—kidney cancer	2.4e-05	0.000232	CcSEcCtD
Aprepitant—Conjunctivitis—Doxorubicin—kidney cancer	2.4e-05	0.000232	CcSEcCtD
Aprepitant—Urinary tract infection—Doxorubicin—kidney cancer	2.4e-05	0.000232	CcSEcCtD
Aprepitant—Nervous system disorder—Capecitabine—kidney cancer	2.4e-05	0.000231	CcSEcCtD
Aprepitant—Thrombocytopenia—Capecitabine—kidney cancer	2.39e-05	0.000231	CcSEcCtD
Aprepitant—Tachycardia—Capecitabine—kidney cancer	2.38e-05	0.00023	CcSEcCtD
Aprepitant—Vomiting—Vincristine—kidney cancer	2.38e-05	0.00023	CcSEcCtD
Aprepitant—Skin disorder—Capecitabine—kidney cancer	2.37e-05	0.000229	CcSEcCtD
Aprepitant—Urticaria—Paclitaxel—kidney cancer	2.36e-05	0.000228	CcSEcCtD
Aprepitant—Rash—Vincristine—kidney cancer	2.36e-05	0.000228	CcSEcCtD
Aprepitant—Hyperhidrosis—Capecitabine—kidney cancer	2.36e-05	0.000228	CcSEcCtD
Aprepitant—Dermatitis—Vincristine—kidney cancer	2.36e-05	0.000228	CcSEcCtD
Aprepitant—Haematuria—Doxorubicin—kidney cancer	2.35e-05	0.000227	CcSEcCtD
Aprepitant—Abdominal pain—Paclitaxel—kidney cancer	2.35e-05	0.000227	CcSEcCtD
Aprepitant—Body temperature increased—Paclitaxel—kidney cancer	2.35e-05	0.000227	CcSEcCtD
Aprepitant—Headache—Vincristine—kidney cancer	2.35e-05	0.000227	CcSEcCtD
Aprepitant—Anorexia—Capecitabine—kidney cancer	2.33e-05	0.000225	CcSEcCtD
Aprepitant—Hypotension—Capecitabine—kidney cancer	2.28e-05	0.00022	CcSEcCtD
Aprepitant—Vomiting—Gemcitabine—kidney cancer	2.26e-05	0.000218	CcSEcCtD
Aprepitant—Bradycardia—Doxorubicin—kidney cancer	2.26e-05	0.000218	CcSEcCtD
Aprepitant—Rash—Gemcitabine—kidney cancer	2.24e-05	0.000217	CcSEcCtD
Aprepitant—Dermatitis—Gemcitabine—kidney cancer	2.24e-05	0.000216	CcSEcCtD
Aprepitant—Headache—Gemcitabine—kidney cancer	2.23e-05	0.000215	CcSEcCtD
Aprepitant—Nausea—Vincristine—kidney cancer	2.23e-05	0.000215	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Capecitabine—kidney cancer	2.23e-05	0.000215	CcSEcCtD
Aprepitant—Insomnia—Capecitabine—kidney cancer	2.21e-05	0.000213	CcSEcCtD
Aprepitant—Hypoaesthesia—Doxorubicin—kidney cancer	2.21e-05	0.000213	CcSEcCtD
Aprepitant—Pharyngitis—Doxorubicin—kidney cancer	2.2e-05	0.000212	CcSEcCtD
Aprepitant—Paraesthesia—Capecitabine—kidney cancer	2.19e-05	0.000212	CcSEcCtD
Aprepitant—Hypersensitivity—Paclitaxel—kidney cancer	2.19e-05	0.000212	CcSEcCtD
Aprepitant—Urinary tract disorder—Doxorubicin—kidney cancer	2.19e-05	0.000211	CcSEcCtD
Aprepitant—Connective tissue disorder—Doxorubicin—kidney cancer	2.18e-05	0.00021	CcSEcCtD
Aprepitant—Dyspnoea—Capecitabine—kidney cancer	2.18e-05	0.00021	CcSEcCtD
Aprepitant—Urethral disorder—Doxorubicin—kidney cancer	2.17e-05	0.00021	CcSEcCtD
Aprepitant—Dyspepsia—Capecitabine—kidney cancer	2.15e-05	0.000208	CcSEcCtD
Aprepitant—Asthenia—Paclitaxel—kidney cancer	2.14e-05	0.000206	CcSEcCtD
Aprepitant—Decreased appetite—Capecitabine—kidney cancer	2.12e-05	0.000205	CcSEcCtD
Aprepitant—Nausea—Gemcitabine—kidney cancer	2.11e-05	0.000204	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Capecitabine—kidney cancer	2.11e-05	0.000204	CcSEcCtD
Aprepitant—Fatigue—Capecitabine—kidney cancer	2.11e-05	0.000203	CcSEcCtD
Aprepitant—Pruritus—Paclitaxel—kidney cancer	2.11e-05	0.000203	CcSEcCtD
Aprepitant—Erythema multiforme—Doxorubicin—kidney cancer	2.1e-05	0.000202	CcSEcCtD
Aprepitant—Constipation—Capecitabine—kidney cancer	2.09e-05	0.000202	CcSEcCtD
Aprepitant—Pain—Capecitabine—kidney cancer	2.09e-05	0.000202	CcSEcCtD
Aprepitant—Eye disorder—Doxorubicin—kidney cancer	2.07e-05	0.0002	CcSEcCtD
Aprepitant—Tinnitus—Doxorubicin—kidney cancer	2.07e-05	0.0002	CcSEcCtD
Aprepitant—Cardiac disorder—Doxorubicin—kidney cancer	2.06e-05	0.000199	CcSEcCtD
Aprepitant—Flushing—Doxorubicin—kidney cancer	2.06e-05	0.000199	CcSEcCtD
Aprepitant—Diarrhoea—Paclitaxel—kidney cancer	2.04e-05	0.000197	CcSEcCtD
Aprepitant—Feeling abnormal—Capecitabine—kidney cancer	2.01e-05	0.000194	CcSEcCtD
Aprepitant—Angiopathy—Doxorubicin—kidney cancer	2.01e-05	0.000194	CcSEcCtD
Aprepitant—Immune system disorder—Doxorubicin—kidney cancer	2e-05	0.000193	CcSEcCtD
Aprepitant—Gastrointestinal pain—Capecitabine—kidney cancer	2e-05	0.000193	CcSEcCtD
Aprepitant—Mediastinal disorder—Doxorubicin—kidney cancer	2e-05	0.000193	CcSEcCtD
Aprepitant—Chills—Doxorubicin—kidney cancer	1.99e-05	0.000192	CcSEcCtD
Aprepitant—Dizziness—Paclitaxel—kidney cancer	1.97e-05	0.00019	CcSEcCtD
Aprepitant—Alopecia—Doxorubicin—kidney cancer	1.96e-05	0.000189	CcSEcCtD
Aprepitant—Mental disorder—Doxorubicin—kidney cancer	1.94e-05	0.000188	CcSEcCtD
Aprepitant—Urticaria—Capecitabine—kidney cancer	1.94e-05	0.000187	CcSEcCtD
Aprepitant—Body temperature increased—Capecitabine—kidney cancer	1.93e-05	0.000187	CcSEcCtD
Aprepitant—Abdominal pain—Capecitabine—kidney cancer	1.93e-05	0.000187	CcSEcCtD
Aprepitant—Erythema—Doxorubicin—kidney cancer	1.93e-05	0.000186	CcSEcCtD
Aprepitant—Malnutrition—Doxorubicin—kidney cancer	1.93e-05	0.000186	CcSEcCtD
Aprepitant—Flatulence—Doxorubicin—kidney cancer	1.9e-05	0.000184	CcSEcCtD
Aprepitant—Vomiting—Paclitaxel—kidney cancer	1.89e-05	0.000183	CcSEcCtD
Aprepitant—Dysgeusia—Doxorubicin—kidney cancer	1.89e-05	0.000182	CcSEcCtD
Aprepitant—Rash—Paclitaxel—kidney cancer	1.88e-05	0.000181	CcSEcCtD
Aprepitant—Dermatitis—Paclitaxel—kidney cancer	1.88e-05	0.000181	CcSEcCtD
Aprepitant—Back pain—Doxorubicin—kidney cancer	1.87e-05	0.00018	CcSEcCtD
Aprepitant—Headache—Paclitaxel—kidney cancer	1.86e-05	0.00018	CcSEcCtD
Aprepitant—Muscle spasms—Doxorubicin—kidney cancer	1.86e-05	0.000179	CcSEcCtD
Aprepitant—Hypersensitivity—Capecitabine—kidney cancer	1.8e-05	0.000174	CcSEcCtD
Aprepitant—Ill-defined disorder—Doxorubicin—kidney cancer	1.79e-05	0.000173	CcSEcCtD
Aprepitant—Anaemia—Doxorubicin—kidney cancer	1.78e-05	0.000172	CcSEcCtD
Aprepitant—Nausea—Paclitaxel—kidney cancer	1.77e-05	0.000171	CcSEcCtD
Aprepitant—Asthenia—Capecitabine—kidney cancer	1.75e-05	0.000169	CcSEcCtD
Aprepitant—Malaise—Doxorubicin—kidney cancer	1.74e-05	0.000168	CcSEcCtD
Aprepitant—Syncope—Doxorubicin—kidney cancer	1.73e-05	0.000167	CcSEcCtD
Aprepitant—Pruritus—Capecitabine—kidney cancer	1.73e-05	0.000167	CcSEcCtD
Aprepitant—Palpitations—Doxorubicin—kidney cancer	1.71e-05	0.000165	CcSEcCtD
Aprepitant—Loss of consciousness—Doxorubicin—kidney cancer	1.7e-05	0.000164	CcSEcCtD
Aprepitant—Cough—Doxorubicin—kidney cancer	1.68e-05	0.000163	CcSEcCtD
Aprepitant—Convulsion—Doxorubicin—kidney cancer	1.67e-05	0.000161	CcSEcCtD
Aprepitant—Diarrhoea—Capecitabine—kidney cancer	1.67e-05	0.000161	CcSEcCtD
Aprepitant—Hypertension—Doxorubicin—kidney cancer	1.67e-05	0.000161	CcSEcCtD
Aprepitant—Myalgia—Doxorubicin—kidney cancer	1.64e-05	0.000159	CcSEcCtD
Aprepitant—Arthralgia—Doxorubicin—kidney cancer	1.64e-05	0.000159	CcSEcCtD
Aprepitant—Chest pain—Doxorubicin—kidney cancer	1.64e-05	0.000159	CcSEcCtD
Aprepitant—Anxiety—Doxorubicin—kidney cancer	1.64e-05	0.000158	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	1.63e-05	0.000158	CcSEcCtD
Aprepitant—Discomfort—Doxorubicin—kidney cancer	1.62e-05	0.000157	CcSEcCtD
Aprepitant—Dizziness—Capecitabine—kidney cancer	1.62e-05	0.000156	CcSEcCtD
Aprepitant—Dry mouth—Doxorubicin—kidney cancer	1.61e-05	0.000155	CcSEcCtD
Aprepitant—Confusional state—Doxorubicin—kidney cancer	1.59e-05	0.000153	CcSEcCtD
Aprepitant—Oedema—Doxorubicin—kidney cancer	1.57e-05	0.000152	CcSEcCtD
Aprepitant—Anaphylactic shock—Doxorubicin—kidney cancer	1.57e-05	0.000152	CcSEcCtD
Aprepitant—Infection—Doxorubicin—kidney cancer	1.56e-05	0.000151	CcSEcCtD
Aprepitant—Vomiting—Capecitabine—kidney cancer	1.55e-05	0.00015	CcSEcCtD
Aprepitant—Shock—Doxorubicin—kidney cancer	1.55e-05	0.00015	CcSEcCtD
Aprepitant—Nervous system disorder—Doxorubicin—kidney cancer	1.54e-05	0.000149	CcSEcCtD
Aprepitant—Thrombocytopenia—Doxorubicin—kidney cancer	1.54e-05	0.000149	CcSEcCtD
Aprepitant—Rash—Capecitabine—kidney cancer	1.54e-05	0.000149	CcSEcCtD
Aprepitant—Dermatitis—Capecitabine—kidney cancer	1.54e-05	0.000149	CcSEcCtD
Aprepitant—Tachycardia—Doxorubicin—kidney cancer	1.54e-05	0.000148	CcSEcCtD
Aprepitant—Headache—Capecitabine—kidney cancer	1.53e-05	0.000148	CcSEcCtD
Aprepitant—Skin disorder—Doxorubicin—kidney cancer	1.53e-05	0.000148	CcSEcCtD
Aprepitant—Hyperhidrosis—Doxorubicin—kidney cancer	1.52e-05	0.000147	CcSEcCtD
Aprepitant—Anorexia—Doxorubicin—kidney cancer	1.5e-05	0.000145	CcSEcCtD
Aprepitant—Hypotension—Doxorubicin—kidney cancer	1.47e-05	0.000142	CcSEcCtD
Aprepitant—Nausea—Capecitabine—kidney cancer	1.45e-05	0.00014	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.43e-05	0.000139	CcSEcCtD
Aprepitant—Insomnia—Doxorubicin—kidney cancer	1.42e-05	0.000138	CcSEcCtD
Aprepitant—Paraesthesia—Doxorubicin—kidney cancer	1.41e-05	0.000137	CcSEcCtD
Aprepitant—Dyspnoea—Doxorubicin—kidney cancer	1.4e-05	0.000136	CcSEcCtD
Aprepitant—Somnolence—Doxorubicin—kidney cancer	1.4e-05	0.000135	CcSEcCtD
Aprepitant—Dyspepsia—Doxorubicin—kidney cancer	1.39e-05	0.000134	CcSEcCtD
Aprepitant—Decreased appetite—Doxorubicin—kidney cancer	1.37e-05	0.000132	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Doxorubicin—kidney cancer	1.36e-05	0.000131	CcSEcCtD
Aprepitant—Fatigue—Doxorubicin—kidney cancer	1.36e-05	0.000131	CcSEcCtD
Aprepitant—Constipation—Doxorubicin—kidney cancer	1.35e-05	0.00013	CcSEcCtD
Aprepitant—Pain—Doxorubicin—kidney cancer	1.35e-05	0.00013	CcSEcCtD
Aprepitant—Feeling abnormal—Doxorubicin—kidney cancer	1.3e-05	0.000125	CcSEcCtD
Aprepitant—Gastrointestinal pain—Doxorubicin—kidney cancer	1.29e-05	0.000124	CcSEcCtD
Aprepitant—Urticaria—Doxorubicin—kidney cancer	1.25e-05	0.000121	CcSEcCtD
Aprepitant—Body temperature increased—Doxorubicin—kidney cancer	1.24e-05	0.00012	CcSEcCtD
Aprepitant—Abdominal pain—Doxorubicin—kidney cancer	1.24e-05	0.00012	CcSEcCtD
Aprepitant—Hypersensitivity—Doxorubicin—kidney cancer	1.16e-05	0.000112	CcSEcCtD
Aprepitant—Asthenia—Doxorubicin—kidney cancer	1.13e-05	0.000109	CcSEcCtD
Aprepitant—Pruritus—Doxorubicin—kidney cancer	1.11e-05	0.000108	CcSEcCtD
Aprepitant—Diarrhoea—Doxorubicin—kidney cancer	1.08e-05	0.000104	CcSEcCtD
Aprepitant—Dizziness—Doxorubicin—kidney cancer	1.04e-05	0.000101	CcSEcCtD
Aprepitant—Vomiting—Doxorubicin—kidney cancer	1e-05	9.67e-05	CcSEcCtD
Aprepitant—Rash—Doxorubicin—kidney cancer	9.93e-06	9.59e-05	CcSEcCtD
Aprepitant—Dermatitis—Doxorubicin—kidney cancer	9.92e-06	9.58e-05	CcSEcCtD
Aprepitant—Headache—Doxorubicin—kidney cancer	9.87e-06	9.53e-05	CcSEcCtD
Aprepitant—Nausea—Doxorubicin—kidney cancer	9.35e-06	9.03e-05	CcSEcCtD
Aprepitant—CYP1A2—Metabolism—ACY1—kidney cancer	8.52e-06	0.000515	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	8.5e-06	0.000513	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—VEGFA—kidney cancer	8.5e-06	0.000513	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PDHB—kidney cancer	8.48e-06	0.000512	CbGpPWpGaD
Aprepitant—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	8.46e-06	0.000511	CbGpPWpGaD
Aprepitant—CYP2C9—Biological oxidations—POMC—kidney cancer	8.45e-06	0.00051	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CA2—kidney cancer	8.34e-06	0.000503	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL2—kidney cancer	8.27e-06	0.000499	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ALAD—kidney cancer	8.12e-06	0.000491	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—MAPK3—kidney cancer	8.04e-06	0.000486	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CCBL1—kidney cancer	7.97e-06	0.000481	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ST3GAL2—kidney cancer	7.93e-06	0.000479	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	7.91e-06	0.000477	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—GSTM1—kidney cancer	7.89e-06	0.000476	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—HIF1A—kidney cancer	7.88e-06	0.000476	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TSC2—kidney cancer	7.86e-06	0.000475	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—MYC—kidney cancer	7.82e-06	0.000472	CbGpPWpGaD
Aprepitant—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	7.78e-06	0.00047	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ALDH1A1—kidney cancer	7.75e-06	0.000468	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—MAPK1—kidney cancer	7.65e-06	0.000462	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GLIPR1—kidney cancer	7.58e-06	0.000458	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPAT—kidney cancer	7.58e-06	0.000458	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—KDR—kidney cancer	7.54e-06	0.000455	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	7.48e-06	0.000452	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	7.48e-06	0.000451	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CRABP1—kidney cancer	7.43e-06	0.000449	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PGK1—kidney cancer	7.43e-06	0.000449	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—SLC5A3—kidney cancer	7.43e-06	0.000449	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	7.41e-06	0.000447	CbGpPWpGaD
Aprepitant—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	7.37e-06	0.000445	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—LDHB—kidney cancer	7.29e-06	0.00044	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	7.27e-06	0.000439	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PDHB—kidney cancer	7.25e-06	0.000437	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—KRAS—kidney cancer	7.23e-06	0.000436	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—POMC—kidney cancer	7.22e-06	0.000436	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	7.21e-06	0.000435	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—FH—kidney cancer	7.05e-06	0.000426	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—APRT—kidney cancer	7.05e-06	0.000426	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—APC—kidney cancer	6.94e-06	0.000419	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—KIT—kidney cancer	6.94e-06	0.000419	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPAT—kidney cancer	6.91e-06	0.000417	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GLIPR1—kidney cancer	6.91e-06	0.000417	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ITPR2—kidney cancer	6.91e-06	0.000417	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	6.89e-06	0.000416	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	6.82e-06	0.000412	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CCBL1—kidney cancer	6.81e-06	0.000411	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	6.76e-06	0.000408	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—MAPK3—kidney cancer	6.65e-06	0.000401	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—PIK3CA—kidney cancer	6.64e-06	0.000401	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GPC3—kidney cancer	6.63e-06	0.0004	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—POMC—kidney cancer	6.61e-06	0.000399	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ACY1—kidney cancer	6.58e-06	0.000397	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—BRAF—kidney cancer	6.52e-06	0.000394	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CA2—kidney cancer	6.45e-06	0.000389	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—FH—kidney cancer	6.43e-06	0.000388	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—APRT—kidney cancer	6.43e-06	0.000388	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TP53—kidney cancer	6.42e-06	0.000388	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—MAPK1—kidney cancer	6.33e-06	0.000382	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CA9—kidney cancer	6.32e-06	0.000382	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GSTT1—kidney cancer	6.3e-06	0.00038	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ACHE—kidney cancer	6.3e-06	0.00038	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALAD—kidney cancer	6.28e-06	0.000379	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	6.28e-06	0.000379	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	6.16e-06	0.000372	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ST3GAL2—kidney cancer	6.13e-06	0.00037	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—PIK3CA—kidney cancer	6.04e-06	0.000365	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GPC3—kidney cancer	6.04e-06	0.000365	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALDH1A1—kidney cancer	5.99e-06	0.000362	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—KRAS—kidney cancer	5.97e-06	0.000361	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—SCARB1—kidney cancer	5.96e-06	0.00036	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPAT—kidney cancer	5.91e-06	0.000357	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GLIPR1—kidney cancer	5.91e-06	0.000357	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTGS1—kidney cancer	5.9e-06	0.000357	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CA2—kidney cancer	5.88e-06	0.000355	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	5.83e-06	0.000352	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PSMD7—kidney cancer	5.79e-06	0.00035	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	5.77e-06	0.000349	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SLC5A3—kidney cancer	5.74e-06	0.000347	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PGK1—kidney cancer	5.74e-06	0.000347	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALAD—kidney cancer	5.73e-06	0.000346	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—LDHB—kidney cancer	5.63e-06	0.00034	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PDHB—kidney cancer	5.59e-06	0.000338	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ST3GAL2—kidney cancer	5.59e-06	0.000338	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—POMC—kidney cancer	5.57e-06	0.000337	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—FH—kidney cancer	5.49e-06	0.000332	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—APRT—kidney cancer	5.49e-06	0.000332	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—BCHE—kidney cancer	5.49e-06	0.000331	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—PIK3CA—kidney cancer	5.49e-06	0.000331	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALDH1A1—kidney cancer	5.46e-06	0.00033	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—RAF1—kidney cancer	5.45e-06	0.000329	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—RELA—kidney cancer	5.42e-06	0.000327	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—SLC5A5—kidney cancer	5.42e-06	0.000327	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—ERBB2—kidney cancer	5.39e-06	0.000325	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CRABP1—kidney cancer	5.37e-06	0.000324	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	5.37e-06	0.000324	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MTOR—kidney cancer	5.32e-06	0.000321	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CCBL1—kidney cancer	5.26e-06	0.000317	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PGK1—kidney cancer	5.24e-06	0.000316	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SLC5A3—kidney cancer	5.24e-06	0.000316	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—SLC2A1—kidney cancer	5.24e-06	0.000316	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GPC3—kidney cancer	5.16e-06	0.000312	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—LDHB—kidney cancer	5.14e-06	0.00031	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CA2—kidney cancer	5.02e-06	0.000303	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ITPR2—kidney cancer	4.99e-06	0.000302	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CDKN1B—kidney cancer	4.99e-06	0.000301	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALAD—kidney cancer	4.89e-06	0.000296	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CA9—kidney cancer	4.88e-06	0.000295	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL2—kidney cancer	4.88e-06	0.000295	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ST3GAL2—kidney cancer	4.78e-06	0.000288	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.77e-06	0.000288	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CCND1—kidney cancer	4.76e-06	0.000288	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—JUN—kidney cancer	4.75e-06	0.000287	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CTNNB1—kidney cancer	4.72e-06	0.000285	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALDH1A1—kidney cancer	4.67e-06	0.000282	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PTEN—kidney cancer	4.6e-06	0.000278	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GLIPR1—kidney cancer	4.56e-06	0.000275	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPAT—kidney cancer	4.56e-06	0.000275	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTT1—kidney cancer	4.55e-06	0.000275	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ACHE—kidney cancer	4.55e-06	0.000275	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PGK1—kidney cancer	4.48e-06	0.00027	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SLC5A3—kidney cancer	4.48e-06	0.00027	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CA9—kidney cancer	4.45e-06	0.000269	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—LDHB—kidney cancer	4.39e-06	0.000265	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GSTP1—kidney cancer	4.37e-06	0.000264	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.35e-06	0.000263	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—SCARB1—kidney cancer	4.31e-06	0.00026	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTGS1—kidney cancer	4.27e-06	0.000258	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APRT—kidney cancer	4.24e-06	0.000256	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—FH—kidney cancer	4.24e-06	0.000256	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PSMD7—kidney cancer	4.19e-06	0.000253	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CRABP1—kidney cancer	4.15e-06	0.000251	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—VEGFA—kidney cancer	4.15e-06	0.000251	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ABCB1—kidney cancer	4.13e-06	0.00025	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GSTM1—kidney cancer	4.01e-06	0.000242	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GPC3—kidney cancer	3.98e-06	0.000241	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—BCHE—kidney cancer	3.97e-06	0.00024	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MAPK3—kidney cancer	3.93e-06	0.000237	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—SLC5A5—kidney cancer	3.92e-06	0.000237	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CA2—kidney cancer	3.88e-06	0.000234	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ITPR2—kidney cancer	3.86e-06	0.000233	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MYC—kidney cancer	3.82e-06	0.000231	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CA9—kidney cancer	3.81e-06	0.00023	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP1A1—kidney cancer	3.8e-06	0.00023	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CRABP1—kidney cancer	3.79e-06	0.000229	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—SLC2A1—kidney cancer	3.79e-06	0.000229	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALAD—kidney cancer	3.78e-06	0.000228	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MAPK1—kidney cancer	3.74e-06	0.000226	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.72e-06	0.000225	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ST3GAL2—kidney cancer	3.69e-06	0.000223	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALDH1A1—kidney cancer	3.6e-06	0.000218	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.56e-06	0.000215	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—KRAS—kidney cancer	3.53e-06	0.000213	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTT1—kidney cancer	3.52e-06	0.000213	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ACHE—kidney cancer	3.52e-06	0.000213	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ITPR2—kidney cancer	3.52e-06	0.000213	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PGK1—kidney cancer	3.45e-06	0.000209	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC5A3—kidney cancer	3.45e-06	0.000209	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LDHB—kidney cancer	3.39e-06	0.000205	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SCARB1—kidney cancer	3.33e-06	0.000201	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTGS1—kidney cancer	3.3e-06	0.000199	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.25e-06	0.000196	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PIK3CA—kidney cancer	3.24e-06	0.000196	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CRABP1—kidney cancer	3.24e-06	0.000195	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PSMD7—kidney cancer	3.24e-06	0.000195	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTT1—kidney cancer	3.21e-06	0.000194	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ACHE—kidney cancer	3.21e-06	0.000194	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTP1—kidney cancer	3.16e-06	0.000191	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TP53—kidney cancer	3.14e-06	0.000189	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—BCHE—kidney cancer	3.07e-06	0.000185	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SCARB1—kidney cancer	3.04e-06	0.000184	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SLC5A5—kidney cancer	3.03e-06	0.000183	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ITPR2—kidney cancer	3.01e-06	0.000182	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTGS1—kidney cancer	3.01e-06	0.000182	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ABCB1—kidney cancer	2.99e-06	0.00018	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PSMD7—kidney cancer	2.95e-06	0.000178	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CA9—kidney cancer	2.94e-06	0.000177	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SLC2A1—kidney cancer	2.93e-06	0.000177	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTM1—kidney cancer	2.9e-06	0.000175	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.84e-06	0.000171	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—POMC—kidney cancer	2.84e-06	0.000171	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—BCHE—kidney cancer	2.8e-06	0.000169	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.77e-06	0.000167	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SLC5A5—kidney cancer	2.76e-06	0.000167	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP1A1—kidney cancer	2.75e-06	0.000166	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTT1—kidney cancer	2.74e-06	0.000166	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ACHE—kidney cancer	2.74e-06	0.000166	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SLC2A1—kidney cancer	2.67e-06	0.000161	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SCARB1—kidney cancer	2.6e-06	0.000157	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.59e-06	0.000156	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGS1—kidney cancer	2.57e-06	0.000155	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PSMD7—kidney cancer	2.52e-06	0.000152	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CRABP1—kidney cancer	2.5e-06	0.000151	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.48e-06	0.00015	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTP1—kidney cancer	2.44e-06	0.000147	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—BCHE—kidney cancer	2.39e-06	0.000144	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SLC5A5—kidney cancer	2.36e-06	0.000143	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ITPR2—kidney cancer	2.32e-06	0.00014	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ABCB1—kidney cancer	2.31e-06	0.00014	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SLC2A1—kidney cancer	2.28e-06	0.000138	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTGS2—kidney cancer	2.26e-06	0.000137	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.26e-06	0.000136	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTM1—kidney cancer	2.24e-06	0.000135	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTP1—kidney cancer	2.23e-06	0.000134	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.21e-06	0.000134	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP1A1—kidney cancer	2.13e-06	0.000128	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ACHE—kidney cancer	2.12e-06	0.000128	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTT1—kidney cancer	2.12e-06	0.000128	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ABCB1—kidney cancer	2.11e-06	0.000127	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—POMC—kidney cancer	2.05e-06	0.000124	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTM1—kidney cancer	2.05e-06	0.000123	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SCARB1—kidney cancer	2e-06	0.000121	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGS1—kidney cancer	1.98e-06	0.00012	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTEN—kidney cancer	1.97e-06	0.000119	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PSMD7—kidney cancer	1.95e-06	0.000117	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.94e-06	0.000117	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.93e-06	0.000116	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTP1—kidney cancer	1.9e-06	0.000115	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—BCHE—kidney cancer	1.84e-06	0.000111	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.82e-06	0.00011	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ABCB1—kidney cancer	1.8e-06	0.000109	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.76e-06	0.000106	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTM1—kidney cancer	1.75e-06	0.000106	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.75e-06	0.000105	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP1A1—kidney cancer	1.66e-06	0.0001	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTGS2—kidney cancer	1.64e-06	9.88e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.59e-06	9.62e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—POMC—kidney cancer	1.59e-06	9.57e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTP1—kidney cancer	1.47e-06	8.86e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—POMC—kidney cancer	1.45e-06	8.73e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTEN—kidney cancer	1.43e-06	8.61e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CA—kidney cancer	1.39e-06	8.41e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ABCB1—kidney cancer	1.39e-06	8.39e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.36e-06	8.22e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTM1—kidney cancer	1.35e-06	8.14e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.28e-06	7.72e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTGS2—kidney cancer	1.26e-06	7.63e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—POMC—kidney cancer	1.24e-06	7.46e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTGS2—kidney cancer	1.15e-06	6.96e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTEN—kidney cancer	1.1e-06	6.66e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.01e-06	6.08e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTEN—kidney cancer	1.01e-06	6.07e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGS2—kidney cancer	9.85e-07	5.95e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—POMC—kidney cancer	9.53e-07	5.76e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTEN—kidney cancer	8.59e-07	5.19e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CA—kidney cancer	7.78e-07	4.7e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGS2—kidney cancer	7.6e-07	4.59e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CA—kidney cancer	7.09e-07	4.28e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTEN—kidney cancer	6.63e-07	4e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CA—kidney cancer	6.06e-07	3.66e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CA—kidney cancer	4.68e-07	2.82e-05	CbGpPWpGaD
